Illinois General Assembly - Illinois Compiled Statutes

Updating the database of the Illinois Compiled Statutes (ILCS) is an ongoing process. Recent laws may not yet be included in the ILCS database, but they are found on this site as Public Acts soon after they become law. For information concerning the relationship between statutes and Public Acts, refer to the Guide.

Because the statute database is maintained primarily for legislative drafting purposes, statutory changes are sometimes included in the statute database before they take effect. If the source note at the end of a Section of the statutes includes a Public Act that has not yet taken effect, the version of the law that is currently in effect may have already been removed from the database and you should refer to that Public Act to see the changes made to the current law.

215 ILCS 5/356z.50

(215 ILCS 5/356z.50)

    Sec. 356z.50. Comprehensive cancer testing.
    (a) As used in this Section:
    "Comprehensive cancer testing" includes, but is not limited to, the following forms of testing:
        (1) Targeted cancer gene panels.
        (2) Whole-exome genome testing.
        (3) Whole-genome sequencing.
        (4) RNA sequencing.
        (5) Tumor mutation burden.

"Testing of blood or constitutional tissue for cancer predisposition testing" includes, but is not limited to, the following forms of testing:

        (1) Targeted cancer gene panels.
        (2) Whole-exome genome testing.
        (3) Whole-genome sequencing.

(b)     An individual or group policy of accident and health insurance or managed care plan that is amended, delivered, issued, or renewed on or after January 1, 2022 (the effective date of Public Act 102-589) shall provide coverage for medically necessary comprehensive cancer testing and testing of blood or constitutional tissue for cancer predisposition testing as determined by a physician licensed to practice medicine in all of its branches.

(Source: P.A. 102-589, eff. 1-1-22; 102-813, eff. 5-13-22.)